trending Market Intelligence /marketintelligence/en/news-insights/trending/ctAcUOJEMIDn0NjC3oKDHg2 content esgSubNav
In This List

Assembly Biosciences appoints director

Blog

Insight Weekly: Layoffs swell; energy efficiency PE deals defy downturn; 2023 global risk themes

Blog

Insight Weekly: Energy crisis cripples Europe; i-bank incomes rise; US holiday sales outlook

Blog

Japan M&A By the Numbers: Q3 2022

Blog

Insight Weekly: Reviving nuclear power; 2023 outlook for US financials; PE funds fuel EV sector


Assembly Biosciences appoints director

Assembly Biosciences Inc. increased the size of its board to eight members with the appointment of Sue Mahony as a director.

Mahony is president of Lilly Oncology, a senior vice president at Eli Lilly and Co. and a member of the company's executive committee.